Beta-Lactamase-Producing Gram-Negative Bacterial Isolates Among the Patients Attending a Tertiary Care Hospital, Kathmandu, Nepal

Over the times, carbapenems have been the choice of drug for treating multidrug-resistant (MDR) and extended spectrum beta-lactamase (ESBL)-producing organisms. The current study aimed at determining the occurrence of metallo beta-lactamase (MBL) and AmpC beta-lactamase (ABL) in gram negative bacter...

Descripción completa

Detalles Bibliográficos
Autores principales: Pariyar, Manita, Adhikari, Sanjib, Regmi, Ramesh Sharma, Dhungel, Binod, Banjara, Megha Raj, Rijal, Basista Prasad, Rijal, Komal Raj, Ghimire, Prakash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880579/
https://www.ncbi.nlm.nih.gov/pubmed/36713265
http://dx.doi.org/10.1177/11786361221150761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880579/
https://www.ncbi.nlm.nih.gov/pubmed/36713265
http://dx.doi.org/10.1177/11786361221150761

Ejemplares similares